Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

229,711-229,740 of 319,975

filter-aware
26
The slide uses a comparative visual framework to contrast normal vs. stressed replication mechanisms.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
27
The slide uses a combination of a CRISPR screen scatter plot and a biological process diagram to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
28
Uses a puzzle piece metaphor to represent the components of a successful therapeutic strategy.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
29
Includes kinase selectivity tree and four tumor volume growth inhibition charts.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
30
Includes a mechanism of action diagram illustrating 'Therapy Enhanced Synthetic Lethality'.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
31
Shows synergistic effect of BBI-355 with Palbociclib and Erlotinib.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
32
The slide uses a process flow diagram to illustrate the progression from single-agent to combination therapy trials.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
33
The slide highlights the 60mg dose as the MTD (Maximum Tolerated Dose) and shows it crosses the threshold for tumor regression.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
34
The table uses a grid layout to show AE frequency across different dosage cohorts (20mg, 40mg, 60mg, 80mg Q2D, 80mg 2ON/5OFF, 120mg 2ON/5OFF).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
35
Includes legend for dose cohorts and patient IDs; visual evidence of biomarker induction via IHC staining.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
36
The slide uses a Gantt-style timeline to map trial phases against calendar years.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
37
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
38
The slide uses a table structure to map initial drivers to resistance mechanisms, supported by clinical citations and microscopy images.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
39
The slide uses a biological mechanism diagram to explain the therapeutic rationale for BBI-825.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
40
The slide uses a process flow (left to right) to demonstrate the mechanism of action and efficacy.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
41
Includes two distinct experimental setups: prevention of resistance (left) and treatment of established resistance (right).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
42
Includes FISH images, bar chart of copy number, Western blot, and a cell growth curve.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
43
The slide uses a 'STARMAP' acronym to describe the study design.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
44
The slide uses a diagram to link specific cancer types and mutations to resistance mechanisms, ultimately pointing to BBI-825 as the solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market Size1 hit
45
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
46
The slide uses two pie charts to represent patient populations and a central circular diagram to illustrate the biological nodes (Replication Stress, Assembly & Repair, Segregation).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
47
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Loop · Golden Circle1 hit
48
The slide uses a timeline-style progression to frame the company's technology as the next logical evolution in cancer treatment.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
49
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
50
The chart at the bottom illustrates the 'ecDNA revolution' alongside 'Molecular biology' and 'NGS' revolutions.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
51
The table uses a clear contrast-based layout to differentiate the two lead molecules.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
01
Slide 1
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
02
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
03
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
04
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit